Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of 460.75 million as of January 22, 2025. Its market cap has decreased by -40.43% in one year.

Market Cap

460.75M

Enterprise Value

349.36M

Revenue

32.41M

Ranking

n/a

PE Ratio

n/a

Stock Price

214.40

Market Cap Chart

Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 460.75M, an increase of 831.75%. That is a compound annual growth rate of 7.06%.

Market Cap History

Date	Market Cap	% Change
Jan 17, 2025	461.05M	14.29%
Dec 31, 2024	403.42M	-41.27%
Dec 29, 2023	686.90M	-1.77%
Dec 30, 2022	699.29M	-45.56%
Dec 31, 2021	1.28B	51.35%
Dec 31, 2020	848.66M	84.29%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	88.56B
Danel (Adir Yeoshua)	2.53B
Kamada	1.45B
Bait Bakfar	1.05B
Novolog (Pharm-Up 1966)	973.94M
Ilex Medical	834.54M
BrainsWay	710.39M
SofWave Medical	603.50M

Market Cap Rankings